danazol has been researched along with Experimental Pneumococcal Meningitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazargan, N; Farhoudi, A; Mahmoudi, M; Pourpak, Z | 1 |
1 other study(ies) available for danazol and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
Two related cases of primary complement deficiency.
Topics: Adult; Anti-Bacterial Agents; Complement C3; Danazol; Dyspnea; Edema; Female; Genetic Diseases, Inborn; Glomerulonephritis; Humans; Male; Meningitis, Pneumococcal; Pedigree; Stanozolol | 2003 |